ROYAL BANK OF CANADA

Holdings History for Protalix BioTherapeutics, Inc. - COM (PLX)

Symbol: PLX on NYSE
Investment type: Equity - Shares of Stock
Class: COM

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
9/30/2024			$0	0	-1,212	-100%		Q3 2024
6/30/2024	0%		$1K	1.21K	-302	-19.9%	$0.83	Q2 2024
3/31/2024	0%	0%	$2K	1.51K	-20,288	-93.1%	$1.32	Q1 2024
12/31/2023	0%	+0%	$39K	21.8K	+10,664	+95.7%	$1.79	Q4 2023
9/30/2023	0%	+0%	$18K	11.1K	+5,278	+90.1%	$1.62	Q3 2023
6/30/2023			$1K	639			$1.56^*	Q2 2023
6/30/2023	0%	+0%	$12K	5.86K	+5,860	NEW	$2.05	Q2 2023
9/30/2021			$1K	500			$2.00^*	Q3 2021
6/30/2021	0%		$2K	1K	+500	+100%	$2.00	Q2 2021
3/31/2021			$1K	120			$8.33^*	Q1 2021
3/31/2021	0%		$2K	500			$4.00	Q1 2021
12/31/2020	0%		$2K	500			$4.00	Q4 2020
9/30/2020	0%		$2K	500			$4.00	Q3 2020
6/30/2020	0%		$2K	500			$4.00	Q2 2020
3/31/2020	0%		$1K	500			$2.00	Q1 2020
12/31/2019			$3K	661			$4.54^*	Q4 2019

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.